Home › Companies › Applied Therapeutics, Inc.

Applied Therapeutics, Inc. proxy voting records

How asset managers voted at Applied Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number03828A
• SEC CIK1697532

Recent shareholder votes

• June 9, 2025 annual meeting (2024-2025 proxy season): 4 items in Applied Therapeutics, Inc.'s official results (Form 8-K, filed June 12, 2025); lowest support 92% of votes cast (Company's stockholders voted to approve an amendment to our…). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Explore Applied Therapeutics, Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.